Evidence map›Paper›PMID 36296737›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Development of New Natural Lipid-Based Nanoparticles Loaded with Aluminum-Phthalocyanine for Photodynamic Therapy against Melanoma.

Victor Carlos Mello, Victor Hugo Sousa Araújo, Karen Letycia Rodrigues de Paiva, Marina Mesquita Simões, Dafne Caroline Marques, Nelice Roberta da Silva Costa, Isadora Florêncio de Souza, Patricia Bento da Silva, Igor Santos, Raquel Almeida and 11 more

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Effect of Curcumin Pretreatment on the Susceptibility ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  10. Review
  11. Review
  12. Review
  13. A Physiochemical,ACS applied bio materials · 2024
    Article
  14. Article
  15. Article
  16. Nanotechnology as a Promising Method in the Treatment of Skin Cancer.International journal of molecular sciences · 2024
    Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 2 institutions in 1 country.

Victor Carlos MelloPostgraduate Program in Animal Biology, Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasília, Brasília 70910-900, DF, Brazil.
Victor Hugo Sousa AraújoSchool of Pharmaceutical Sciences, São Paulo State University, Araraquara 14800-903, SP, Brazil.
Karen Letycia Rodrigues de PaivaLaboratory of Microscopy and Microanalysis, Department of Cell Biology, Institute of Biological Sciences, University of Brasília, Brasília 70910-900, DF, Brazil.
Marina Mesquita SimõesLaboratory of Microscopy and Microanalysis, Department of Cell Biology, Institute of Biological Sciences, University of Brasília, Brasília 70910-900, DF, Brazil.ORCID 0000-0002-9814-5827
Dafne Caroline MarquesLaboratory of Microscopy and Microanalysis, Department of Cell Biology, Institute of Biological Sciences, University of Brasília, Brasília 70910-900, DF, Brazil.
Nelice Roberta da Silva CostaLaboratory of Nanobiotechnology, Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasilia, Brasília 70910-900, DF, Brazil.
Isadora Florêncio de SouzaLaboratory of Microscopy and Microanalysis, Department of Cell Biology, Institute of Biological Sciences, University of Brasília, Brasília 70910-900, DF, Brazil.
Patricia Bento da SilvaLaboratory of Nanobiotechnology, Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasilia, Brasília 70910-900, DF, Brazil.ORCID 0000-0001-8335-0708
Igor SantosLaboratory of Immunology and Inflammation, Department of Cell Biology, University of Brasilia, Brasília 70910-900, DF, Brazil.ORCID 0000-0001-6036-6694
Raquel AlmeidaLaboratory of Immunology and Inflammation, Department of Cell Biology, University of Brasilia, Brasília 70910-900, DF, Brazil.
Kelly Grace MagalhãesLaboratory of Immunology and Inflammation, Department of Cell Biology, University of Brasilia, Brasília 70910-900, DF, Brazil.ORCID 0000-0002-7435-5272
Sebastião William da SilvaOptical Spectroscopy Laboratory, Institute of Physics, University of Brasilia, Brasília 70910-900, DF, Brazil.ORCID 0000-0003-4483-9687
Alexandre Silva SantosOptical Spectroscopy Laboratory, Institute of Physics, University of Brasilia, Brasília 70910-900, DF, Brazil.
Fabiane Veiga-SouzaLaboratory of Protein Chemistry and Biochemistry, Department of Cell Biology, Institute of Biology, University of Brasília, Brasília 70910-900, DF, Brazil.ORCID 0000-0002-5300-5038
Paulo Eduardo Narcizo SouzaLaboratory of Electron Paramagnetic Resonance, Institute of Physics, University of Brasília, Brasília 70910-900, DF, Brazil.
Marina Arantes RaddichiLaboratory of Microscopy and Microanalysis, Department of Cell Biology, Institute of Biological Sciences, University of Brasília, Brasília 70910-900, DF, Brazil.ORCID 0000-0001-9149-316X
João Paulo Figueiró LongoLaboratory of Nanobiotechnology, Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasilia, Brasília 70910-900, DF, Brazil.ORCID 0000-0002-5154-7263
Jennifer Thayanne Cavalcante de AraújoSchool of Pharmaceutical Sciences, São Paulo State University, Araraquara 14800-903, SP, Brazil.ORCID 0000-0003-2547-1012
Luis Alexandre MuehlmannFaculty of Ceilandia, University of Brasilia, Brasília 70910-900, DF, Brazil.
Marlus ChorilliSchool of Pharmaceutical Sciences, São Paulo State University, Araraquara 14800-903, SP, Brazil.ORCID 0000-0002-6698-0545
Sônia Nair BáoLaboratory of Microscopy and Microanalysis, Department of Cell Biology, Institute of Biological Sciences, University of Brasília, Brasília 70910-900, DF, Brazil.ORCID 0000-0002-9873-3098
Universidade de Brasília · BRUniversidade Estadual Paulista (Unesp) · BR

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior 0001Financiadora de Estudos e Projetos 01.08.0457.00Foundation for Research Support of the Federal District 00.193.00000920/2020-23Foundation for Research Support of the Federal District 00.193.00001053/2021-24National Council for Scientific and Technological Development 302355/2016-2National Council for Scientific and Technological Development 401957/2016-0National Council for Scientific and Technological Development 40356/2021São Paulo Research Foundation 19/10261-2São Paulo Research Foundation 19/23638-7
6 · The paper itself

Abstract

Photodynamic therapy (PDT) mediated by photosensitizers loaded in nanostructures as solid lipid nanoparticles has been pinpointed as an effective and safe treatment against different skin cancers. Amazon butters have an interesting lipid composition when it comes to forming solid lipid nanoparticles (SLN). In the present report, a new third-generation photosensitizing system consisting of aluminum-phthalocyanine associated with Amazon butter-based solid lipid nanoparticles (SLN-AlPc) is described. The SLN was developed using murumuru butter, and a monodisperse population of nanodroplets with a hydrodynamic diameter of approximately 40 nm was obtained. The study of the permeation of these AlPc did not permeate the analyzed skin, but when incorporated into the system, SLN-AlPc allowed permeation of almost 100% with 8 h of contact. It must be emphasized that SLN-AlPc was efficient for carrying aluminum-phthalocyanine photosensitizers and exhibited no toxicity in the dark. Photoactivated SLN-AlPc exhibited a 50% cytotoxicity concentration (IC

Indexed as

Amazon butterscancerdrug delivery systemsphotodynamic therapythird-generation photosensitizers

Identifiers

PMID36296737
PMCPMC9609910
OpenAlexW4304182689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.